Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03741920 · ClinicalTrials.gov registry record · NA
Evaluation of the Personal KinetiGraph™ (PKG™) to Improve Insight Into Parkinson's Disease Status
A NA study of Parkinson Disease, sponsored by Global Kinetics Corporation.
- Active
- Registry status
- NA
- Development phase
- 231
- Enrollment target
- 12
- Study locations
NCT03741920: Active NA study of Parkinson Disease, sponsored by Global Kinetics Corporation.
NCT03741920 is a NA study of Parkinson Disease that is active but no longer recruiting, run by Global Kinetics Corporation. The registered enrollment target is 231 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (96% lower). The trial reports 12 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03741920, a NA study of Parkinson Disease, is active but no longer recruiting, sponsored by Global Kinetics Corporation.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 231 participants
- Enrollment target
- 12
- Study locations
Study Summary
The primary objective is to understand the utility of Personal KinetiGraph movement recording system data in the clinical management of Parkinson's disease (PD) in routine clinical care at a movement disorders clinic. Specifically: 1. Measure medication use and clinical management plan changes in a large, multicenter cohort among participants undergoing a clinical assessment with an MDS in which the MDS reviews the participant's PKG during the clinical assessment in half of the enrolled participants (PKG + Group) and in half of the enrolled participants the MDS completes the clinical assessment without the PKG (PKG- Group). 2. Determine the association between frequency of medication changes, the PKG information, and other clinical assessments among participants with and without a PKG report of their PD motor status available to the clinician at the time of evaluation.
Primary Outcome
The proportion of patients in which the clinical management plan was changed in patients followed in the PKG- Group (clinician standard of care) compared to the PKG+ Group (clinician standard of care with the use of PKG data).
Conditions Studied
Interventions
- DEVICE Personal KinetiGraph™ (PKG™)
Study Locations (12)
Florida
- Parkinson's Disease and Movement Disorders Center - Boca Raton
- University of Florida - Gainesville
- University of Miami - Miami
- University of South Florida - Tampa
California
- Sutter Health - Sacramento
- University of California - San Diego
New York
- Northwell Health - Great Neck
- New York University - New York
Kansas
- University of Kansas Medical Center - Kansas City
Maryland
- Johns Hopkins Medical Institute - Baltimore
Michigan
- Michigan State University - East Lansing
Texas
- University of Texas - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 231 participants |
| Start Date | 2017-05-17 |
| Est. Completion | 2025-10 |
| Phase | NA |
What the registry record for NCT03741920 still lists
NCT03741920 is an interventional study that assigns participants to a tested intervention. The registered 231 participants enrollment target is mid-sized for trials with a published cap, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which Personal KinetiGraph™ (PKG™) is the first listed.
NCT03741920 lists 12 locations in 7 states (Florida, California, New York).
Frequently Asked Questions
What is clinical trial NCT03741920 about?
NCT03741920 is a clinical study titled "Evaluation of the Personal KinetiGraph™ (PKG™) to Improve Insight Into Parkinson's Disease Status". The primary objective is to understand the utility of Personal KinetiGraph movement recording system data in the clinical management of Parkinson's disease (PD) in routine clinical care at a movement disorders clinic. Specifically: 1. Measure medication use and clinical management plan changes in a...
What is the current status of trial NCT03741920?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 231 participants. The study started on 2017-05-17. Estimated completion is 2025-10.
What conditions does trial NCT03741920 study?
This clinical trial studies the following conditions: Parkinson Disease.
What interventions are being tested in trial NCT03741920?
The interventions under investigation include: Personal KinetiGraph™ (PKG™) (DEVICE).
Who is sponsoring clinical trial NCT03741920?
This trial is sponsored by Global Kinetics Corporation, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03741920 being conducted?
This trial has 12 study locations across California, Florida, Kansas, Maryland, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03741920's enrollment target sits among peer trials
231 42nd of 297 higher than 256 of 297 other Parkinson Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Parkinson Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Neurophysiology of Reward Signaling in Parkinson's Disease
RECRUITING · NA
-
Balance Tele-Rehab in Parkinson's Disease Parkinson's Disease
RECRUITING · NA
-
Rock Steady Boxing: A Community Based In Person Class
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04077099 · 231 participants · Phase 1
A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer
- NCT05019495 · 231 participants · NA
Optimizing Tobacco Treatment Delivery for People Living With HIV
- NCT06023589 · 231 participants · Phase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
- NCT06734351 · 231 participants · Phase 3
A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adult Participants Compared to JUVÉDERM VOLUMA XC for Improvement of Mid-Face Volume
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI